研究目的
To develop a sensitive and simple method for the detection of chondroitin sulfate (CS) in clinical settings and pharmacy quality control using a ratiometric fluorescence strategy based on carbon dots quenched FAM-labeled ssDNA.
研究成果
The developed ratiometric fluorescence strategy based on P-NCDs/F-ssDNA is a simple, sensitive, and reproducible method for CS detection. It has been successfully applied to real samples, demonstrating its potential for clinical diagnosis and pharmaceutical quality control.
研究不足
The method's sensitivity to high salt concentrations and the need for optimization of pH and temperature conditions for different sample types.
1:Experimental Design and Method Selection:
A ratiometric fluorescence strategy was designed using P-NCDs and F-ssDNA for CS detection. The method leverages the electrostatic interaction between P-NCDs and F-ssDNA, and the competitive displacement of F-ssDNA by CS.
2:Sample Selection and Data Sources:
Joint fluid samples from arthritic patients, chondroitin sulfate tablets, and chondroitin sulfate eye drops were used to test the method's applicability.
3:List of Experimental Equipment and Materials:
P-NCDs were prepared from citric acid and L-glutathione. F-ssDNA was used as the fluorescent probe. Synchronous fluorescence spectrometry was employed for detection.
4:Experimental Procedures and Operational Workflow:
P-NCDs were mixed with F-ssDNA to form P-NCDs/F-ssDNA. CS was added to displace F-ssDNA, and the fluorescence changes were monitored.
5:Data Analysis Methods:
The ratio of fluorescence intensities (FF-ssDNA/FP-NCDs) was used to quantify CS concentration, with a linear range of 0.05–2.0 μg/mL.
独家科研数据包,助您复现前沿成果,加速创新突破
获取完整内容